Sort
50,496 grants matching “lung cancer”
Novel metabolomic contrast probes for human lung cancer characterization
$1,330,729Christian T Farrar · Massachusetts General Hospital · R01 · FY2025 · CA
Novel Targets for Immunotherapy
$1,330,078Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,330,042Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer
$1,329,129Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
$1,328,312Samuel E. Adunyah · Meharry Medical College · U54 · FY2012 · CA
Regulation Of Intracellular Iron Metabolism
$1,328,253Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Studies of Receptor Interactions and Effects of Alarmins
$1,327,663Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,327,446Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Multiscale Mathematical Modeling of Cancer Progression
$1,327,383Vito Quaranta · Vanderbilt University · U54 · FY2011 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$1,327,312University Of Colorado Denver · N01 · FY2009 · CA
Role of CEBP transcription factors in regulating cell growth and tumorigenesis
$1,327,149Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Comparative Modeling of Lung Cancer Control Policies
$1,326,517Chung Yin Kong · Massachusetts General Hospital · U01 · FY2014 · CA
Deep South CanCORS Colorectal and Lung Cancer PDCR Site
$1,325,014University Of Alabama At Birmingham · U01 · FY2003 · CA
Contrast-Enhanced and Image-Guided Surgery of Lung Cancer
$1,323,836Shuming Nie · Emory University · R01 · FY2012 · CA
Molecular Tumorigenesis of Bladder Cancer
$1,323,503Xue-Ru Wu · New York University School Of Medicine · P01 · FY2013 · CA
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$1,323,228Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$1,323,226Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
$1,322,758David McCormick · Iit Research Institute · N01 · FY2010 · CA
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center
$1,322,710John J Heine · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2025 · CA
Nonmyeloablative allogeneic PBSC in globin disorders
$1,322,542John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Comparative Mechanisms of Cancer Chemoprevention
$1,321,997Roderick H Dashwood · Oregon State University · P01 · FY2010 · CA
Role of CEBP transcription factors in regulating cell growth and tumorigenesis
$1,321,912Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
PLCO Trial Etiologic and Early Marker Study
$1,321,719Steven Moore · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$1,321,621Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · UG1 · FY2024 · CA
Mechanisms of transcriptional and replicative mutagenesis
$1,321,620Paul Doetsch · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES